Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. (Q35919276)
Jump to navigation
Jump to search
scientific article published in March 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. |
scientific article published in March 1998 |
Statements
1 reference
Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. (English)
1 reference
Zhang S
1 reference
Ramsay ES
1 reference
Mock BA
1 reference
1 March 1998
1 reference
2429-2434
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference